NANOVIRICIDES, INC. Debt Instrument, Interest Rate, Effective Percentage
NANOVIRICIDES, INC. (NNVC) had Debt Instrument, Interest Rate, Effective Percentage of 8.00% as of 2013-09-30, per its 10-Q/A filed 2013-11-18.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2015-02-23
- 2013-09-30: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2013-06-30: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2013-03-31: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
- 2013-02-02: Debt Instrument, Interest Rate, Effective Percentage 8.00%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2013-09-30 | 8.00% 10-Q/A · filed 2013-11-18 |
| 2013-06-30 | 8.00% 10-K · filed 2015-02-23 |
| 2013-03-31 | 8.00% 10-Q/A · filed 2013-05-20 |
| 2013-02-02 | 8.00% 10-Q · filed 2014-02-14 |
| 2013-02-01 | 8.00% 10-K · filed 2015-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |